Transmedics Group Inc
NASDAQ:TMDX
Transmedics Group Inc
Revenue
Transmedics Group Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Transmedics Group Inc
NASDAQ:TMDX
|
Revenue
$296.9m
|
CAGR 3-Years
128%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Transmedics Group Inc
Revenue Breakdown
Breakdown by Geography
Transmedics Group Inc
Breakdown by Segments
Transmedics Group Inc
Total Revenue:
241.6m
USD
|
Product:
176m
USD
|
Service Revenue:
65.6m
USD
|
See Also
What is Transmedics Group Inc's Revenue?
Revenue
296.9m
USD
Based on the financial report for Mar 31, 2024, Transmedics Group Inc's Revenue amounts to 296.9m USD.
What is Transmedics Group Inc's Revenue growth rate?
Revenue CAGR 5Y
81%
Over the last year, the Revenue growth was 149%. The average annual Revenue growth rates for Transmedics Group Inc have been 128% over the past three years , 81% over the past five years .